Cargando…

Hyperinflation and reduced diffusing capacity predict prognosis in SCLC: value of extended pre-therapeutic lung function testing

BACKGROUND: Small cell lung cancer (SCLC) is characterized by aggressive growth and poor prognosis. Although SCLC affects nearly exclusively heavy smokers and leads to frequent respiratory symptoms, the impact of pre-therapeutic lung function testing in SCLC is sparely investigated until now. Theref...

Descripción completa

Detalles Bibliográficos
Autores principales: Kahnert, Kathrin, Lempert, Lilli Maria, Behr, Jürgen, Elsner, Laura, Bolt, Toki, Tufman, Amanda, Kauffmann-Guerrero, Diego
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676075/
https://www.ncbi.nlm.nih.gov/pubmed/37997884
http://dx.doi.org/10.1177/17534666231199670
_version_ 1785149902596079616
author Kahnert, Kathrin
Lempert, Lilli Maria
Behr, Jürgen
Elsner, Laura
Bolt, Toki
Tufman, Amanda
Kauffmann-Guerrero, Diego
author_facet Kahnert, Kathrin
Lempert, Lilli Maria
Behr, Jürgen
Elsner, Laura
Bolt, Toki
Tufman, Amanda
Kauffmann-Guerrero, Diego
author_sort Kahnert, Kathrin
collection PubMed
description BACKGROUND: Small cell lung cancer (SCLC) is characterized by aggressive growth and poor prognosis. Although SCLC affects nearly exclusively heavy smokers and leads to frequent respiratory symptoms, the impact of pre-therapeutic lung function testing in SCLC is sparely investigated until now. Therefore, we sought to examine whether we could find prognostic markers in pre-therapeutic lung function testing of SCLC patients. PATIENTS AND METHODS: We retrospectively analysed a cohort of 205 patients with the diagnosis of SCLC between 2010 and 2018. Pre-therapeutic values of spirometry, body plethysmography and measurement of diffusing capacity was extracted from patients’ charts. Comparisons between groups were performed using the Mann–Whitney U-test or by chi-square tests as appropriate. Kaplan–Meier analyses and COX-regression models were performed to correlate lung function parameters with patients’ outcome. RESULTS: Airway obstruction itself, or the diagnosis chronic obstructive pulmonary disease (COPD) based on GOLD definitions did not correlate with survival in SCLC patients. Hyperinflation measured by increased residual volume and residual volume to total lung capacity ratio (log-rank p < 0.001) and reduced diffusing capacity (log-rank p = 0.007) were associated with reduced survival. Furthermore, patients with hyperinflation as well as impairments in gas exchange representing an emphysematic phenotype had the worst outcome (log-rank p < 0.001). CONCLUSION: We recommend including body plethysmography and measurement of diffusing capacity in the pre-therapeutic assessment of SCLC patients. Our findings suggest that reduction of hyperinflation may lead to better outcome in SCLC patients. Thus, in addition to effective tumour therapy, adequate therapy of the comorbidity of COPD should also be provided. In particular, measures to reduce hyperinflation by means of dual bronchodilation as well as respiratory physiotherapy should be further assessed in this setting.
format Online
Article
Text
id pubmed-10676075
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-106760752023-11-24 Hyperinflation and reduced diffusing capacity predict prognosis in SCLC: value of extended pre-therapeutic lung function testing Kahnert, Kathrin Lempert, Lilli Maria Behr, Jürgen Elsner, Laura Bolt, Toki Tufman, Amanda Kauffmann-Guerrero, Diego Ther Adv Respir Dis Original Research BACKGROUND: Small cell lung cancer (SCLC) is characterized by aggressive growth and poor prognosis. Although SCLC affects nearly exclusively heavy smokers and leads to frequent respiratory symptoms, the impact of pre-therapeutic lung function testing in SCLC is sparely investigated until now. Therefore, we sought to examine whether we could find prognostic markers in pre-therapeutic lung function testing of SCLC patients. PATIENTS AND METHODS: We retrospectively analysed a cohort of 205 patients with the diagnosis of SCLC between 2010 and 2018. Pre-therapeutic values of spirometry, body plethysmography and measurement of diffusing capacity was extracted from patients’ charts. Comparisons between groups were performed using the Mann–Whitney U-test or by chi-square tests as appropriate. Kaplan–Meier analyses and COX-regression models were performed to correlate lung function parameters with patients’ outcome. RESULTS: Airway obstruction itself, or the diagnosis chronic obstructive pulmonary disease (COPD) based on GOLD definitions did not correlate with survival in SCLC patients. Hyperinflation measured by increased residual volume and residual volume to total lung capacity ratio (log-rank p < 0.001) and reduced diffusing capacity (log-rank p = 0.007) were associated with reduced survival. Furthermore, patients with hyperinflation as well as impairments in gas exchange representing an emphysematic phenotype had the worst outcome (log-rank p < 0.001). CONCLUSION: We recommend including body plethysmography and measurement of diffusing capacity in the pre-therapeutic assessment of SCLC patients. Our findings suggest that reduction of hyperinflation may lead to better outcome in SCLC patients. Thus, in addition to effective tumour therapy, adequate therapy of the comorbidity of COPD should also be provided. In particular, measures to reduce hyperinflation by means of dual bronchodilation as well as respiratory physiotherapy should be further assessed in this setting. SAGE Publications 2023-11-24 /pmc/articles/PMC10676075/ /pubmed/37997884 http://dx.doi.org/10.1177/17534666231199670 Text en © The Author(s), 2023 https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research
Kahnert, Kathrin
Lempert, Lilli Maria
Behr, Jürgen
Elsner, Laura
Bolt, Toki
Tufman, Amanda
Kauffmann-Guerrero, Diego
Hyperinflation and reduced diffusing capacity predict prognosis in SCLC: value of extended pre-therapeutic lung function testing
title Hyperinflation and reduced diffusing capacity predict prognosis in SCLC: value of extended pre-therapeutic lung function testing
title_full Hyperinflation and reduced diffusing capacity predict prognosis in SCLC: value of extended pre-therapeutic lung function testing
title_fullStr Hyperinflation and reduced diffusing capacity predict prognosis in SCLC: value of extended pre-therapeutic lung function testing
title_full_unstemmed Hyperinflation and reduced diffusing capacity predict prognosis in SCLC: value of extended pre-therapeutic lung function testing
title_short Hyperinflation and reduced diffusing capacity predict prognosis in SCLC: value of extended pre-therapeutic lung function testing
title_sort hyperinflation and reduced diffusing capacity predict prognosis in sclc: value of extended pre-therapeutic lung function testing
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676075/
https://www.ncbi.nlm.nih.gov/pubmed/37997884
http://dx.doi.org/10.1177/17534666231199670
work_keys_str_mv AT kahnertkathrin hyperinflationandreduceddiffusingcapacitypredictprognosisinsclcvalueofextendedpretherapeuticlungfunctiontesting
AT lempertlillimaria hyperinflationandreduceddiffusingcapacitypredictprognosisinsclcvalueofextendedpretherapeuticlungfunctiontesting
AT behrjurgen hyperinflationandreduceddiffusingcapacitypredictprognosisinsclcvalueofextendedpretherapeuticlungfunctiontesting
AT elsnerlaura hyperinflationandreduceddiffusingcapacitypredictprognosisinsclcvalueofextendedpretherapeuticlungfunctiontesting
AT bolttoki hyperinflationandreduceddiffusingcapacitypredictprognosisinsclcvalueofextendedpretherapeuticlungfunctiontesting
AT tufmanamanda hyperinflationandreduceddiffusingcapacitypredictprognosisinsclcvalueofextendedpretherapeuticlungfunctiontesting
AT kauffmannguerrerodiego hyperinflationandreduceddiffusingcapacitypredictprognosisinsclcvalueofextendedpretherapeuticlungfunctiontesting